targeted-therapy

Documents about targeted-therapy

• The Dual Role of Autophagy in Crizotinib-Treated ALK+ ALCL: From the Lymphoma Cells Drug Resistance to Their Demise#213230HAL (France)
• Prevalence of homologous recombination repair genes alterations in metastatic castration-resistant prostate cancer, a multicentric study#330213HAL (France)
• Treatment of Adult Ph+ LAL With BMS-354825#843019ClinicalTrials.gov
• Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients#850760ClinicalTrials.gov
• A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC#893138ClinicalTrials.gov
• Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids#1017250RI UFLA
• Linker Optimization in Lu-177 Labeled αvβ6-Integrin Binding Peptide Trimers for Targeted Radionuclide Therapy of Cancer#229635Figshare
• Effect of dispersive and relativistic optical model potentials on the production cross-section calculation of 225Ac from 232Th using proton energy#313989ARPHA OAI-PMH Endpoint
• Dupilumab en el tratamiento de pacientes pediátricos con dermatitis atópica moderada a severa en Chile. Serie de 10 casos clínicos#483700Repositorio Universidad del Desarrollo
• Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma#895353ClinicalTrials.gov
• A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy#919015ClinicalTrials.gov
• Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma#1046891ClinicalTrials.gov
• Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review#211595ODU Digital Commons
• Anoikis Resistance and Metastasis of Ovarian Cancer Can Be Overcome by CDK8/19 Mediator Kinase Inhibition#331562Scholar Commons
• Impact of Axillary Surgery on Outcome of Clinically Node Positive Breast Cancer Treated With Neoadjuvant Chemotherapy#410149Scholar Commons
• CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation#801426ClinicalTrials.gov
• Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer#846130ClinicalTrials.gov
• A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site#899093ClinicalTrials.gov
• The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells#158237ClinicalTrials.gov
• Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer#825097ClinicalTrials.gov
• Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer#851168ClinicalTrials.gov
• Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan#147581HAL (France)
• A Study Comparing Modified Lund Concept and Cerebral Perfusion Pressure-targeted Therapy in Secondary Brain Ischaemia.#891133ClinicalTrials.gov
• Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases#980851ClinicalTrials.gov
• Gastric cancer: French intergroup clinical practice guidelines for diagnosis, staging, treatment and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACHBPT, RENAPE, SNFCP)#227016HAL (France)
• Significance of GSH and H<sub>2</sub>S regulation for cancer: an intricate interplay between diet, microbiota, metabolic reprogramming, and immune health#273458Europe PMC
• Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer#321692ClinicalTrials.gov
• Data Sheet 1_Precision identification and targeted therapy for neutrophilic asthma: from molecular mechanisms to clinical translation.pdf#347370Figshare
• A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations#851012ClinicalTrials.gov
• Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc#892364ClinicalTrials.gov
• CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma#908827ClinicalTrials.gov
• On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer#918583ClinicalTrials.gov
• Towards individualized treatment planning for PSMA-targeted radioligand therapy of advanced prostate cancer: from in silico determination of the relative biological effectiveness to image-based red bone marrow dosimetry / Mikhail Rumiantcev ; Betreuer: Guido Böning#661773Deutsche Nationalbibliothek
• A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors#847545ClinicalTrials.gov
• Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy#850167ClinicalTrials.gov
• A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy#890938ClinicalTrials.gov
• Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer#892233ClinicalTrials.gov
• Screening For BCRL In Targeted Therapy For Breast Cancer#914431ClinicalTrials.gov
• Synthesis and design of biologically inspired biocompatible iron oxide nanoparticles for biomedical applications#954824Koc University Digital Collections
• Wellness and Cosmetology Zones in Premium Hotels, Sports Clubs and Wellness Spaces: A Framework for Personalised Skin-Care Based on Postbiotic Microbiome Restoration and Targeted Pigmentation Therapy#433414HAL (France)
• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer#807224ClinicalTrials.gov
• Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering#922264eScholarship
• Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1)#1046121ClinicalTrials.gov
• 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.#891478ClinicalTrials.gov
• Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer#28400ClinicalTrials.gov
• A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy#414352ClinicalTrials.gov
• INTRINSIC AND SYSTEMIC REGULATION OF BRAF: UNCOVERING NEW REGULATION WITH NOVEL MUTATIONS AND MOUSE MODEL, ULTIMATELY ESTABLISHING NOVEL TARGETING SMALL MOLECULES#631198ScholarBank@NUS
• Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma#871703ClinicalTrials.gov
• A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma#875974ClinicalTrials.gov
• Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab#891617ClinicalTrials.gov